tirzepatide shortage fda update reviews decision to put Lilly's on list FDA confirms tirzepatide shortage is

86% of adults taking Wegovy lost 5% or more weight, compared to 31% taking placebo 69% of adults taking Wegovy lost 10% or more weight, compared to 12% taking placebo 51% of adults taking Wegovy lost 15% or more weight, compared to 5% taking placebo* About 1 in 3 adults lost 46 lb or more (20% weight loss) while only 1.7% of adults on placebo experienced the same weight loss

As this happens, skin may begin to appear thinner, less supported, and more prone to lines and sagging

(June 2006)

None of this establishes a benefit, effect or outcome in humans, and cagrilintide is not a licensed medicine

Potential Benefits The use of Ozempic can lead to significant weight loss and improved diabetes management